We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+11.85%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$41.8B
AUM Growth
+$1.48B
(+3.7%)
Cap. Flow
-$1.36B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
19.13%
Holding
1,140
New
93
Increased
265
Reduced
373
Closed
166
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chipotle Mexican Grill
CMG
|
+$197M |
| 2 |
Occidental Petroleum
OXY
|
+$124M |
| 3 |
Boeing
BA
|
+$111M |
| 4 |
argenx
ARGX
|
+$108M |
| 5 |
CMA
Comerica
CMA
|
+$100M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$349M |
| 2 |
Burlington
BURL
|
+$186M |
| 3 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$166M |
| 4 |
Textron
TXT
|
+$160M |
| 5 |
Honeywell
HON
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.51% |
| 2 | Healthcare | 18.38% |
| 3 | Financials | 16.37% |
| 4 | Industrials | 8.21% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Bio-Techne
TECH
$11.2B
| $8.26M | 0.02% |
99,700
-60,300
| -38% | -$4.79M |
|
677
Glaukos
GKOS
$10.1B
| $8.26M | 0.02% |
189,100
-137,900
| -42% | -$6.8M |
|
|
CTLT
678
DELISTED
CATALENT, INC.
CTLT
| $8.24M | 0.02% |
183,000
+100,400
| +122% | +$5.46M |
|
|
BBBY
679
Bed Bath & Beyond
BBBY
$429M
| $8.23M | 0.02% |
+467,500
| New | +$10.1M |
|
680
Carnival Corporation Ltd
CCL
$39.4B
| $8.21M | 0.02% |
1,018,600
+12,900
| +1% | +$111K |
|
|
SVNA
681
DELISTED
7 Acquisition Corp
SVNA
| $8.19M | 0.02% |
800,000
| – | – |
|
|
MRNS
682
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $8.17M | 0.02% |
2,052,500
+815,000
| +66% | +$4.01M |
|
683
Fulcrum Therapeutics
FULC
$288M
| $8.15M | 0.02% |
1,120,000
-200,000
| -15% | -$1.3M |
|
684
Robert Half
RHI
$4.16B
| $8.15M | 0.02% |
110,400
-1,200
| -1% | -$91.5K |
|
685
Huntington Ingalls Industries
HII
$12.7B
| $8.09M | 0.02% |
35,067
-100
| -0.3% | -$23.6K |
|
|
IMGO
686
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $8.09M | 0.02% |
225,000
+25,000
| +13% | +$625K |
|
|
FPAC
687
DELISTED
Far Peak Acquisition Corporation
FPAC
| $8.03M | 0.02% |
800,000
| – | – |
|
|
MSAC
688
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
| $7.96M | 0.02% |
790,000
| – | – |
|
689
GitLab
GTLB
$6.03B
| $7.95M | 0.02% |
175,000
+25,000
| +17% | +$1.13M |
|
|
NGC
690
DELISTED
Northern Genesis Acquisition Corp. III
NGC
| $7.91M | 0.02% |
787,500
| – | – |
|
691
Sable Offshore Corp
SOC
$918M
| $7.84M | 0.02% |
+780,000
| New | +$7.79M |
|
692
Nutanix
NTNX
$16.3B
| $7.82M | 0.02% |
300,000
+50,000
| +20% | +$1.37M |
|
693
Symbotic
SYM
$5.14B
| $7.76M | 0.02% |
650,000
-372,714
| -36% | -$4.34M |
|
|
XFIN
694
DELISTED
ExcelFin Acquisition Corp Class A Common Stock
XFIN
| $7.76M | 0.02% |
755,900
| – | – |
|
|
MTAL
695
DELISTED
Metals Acquisition
MTAL
| $7.73M | 0.02% |
772,523
| – | – |
|
|
696
Burlington
BURL
$23.4B
| $7.7M | 0.02% |
38,000
-1,163,030
| -97% | -$186M |
|
697
Franklin Resources
BEN
$17.3B
| $7.62M | 0.02% |
289,000
-400
| -0.1% | -$9.93K |
|
|
ABGI
698
DELISTED
ABG Acquisition Corp. I
ABGI
| $7.57M | 0.02% |
750,000
| – | – |
|
699
Watsco Inc
WSO
$13.2B
| $7.5M | 0.02% |
30,068
-65,932
| -69% | -$17.3M |
|
700
NRG Energy
NRG
$25B
| $7.46M | 0.02% |
+234,352
| New | +$9.27M |
|
Similar funds
Adage Capital Partners's Q4 2022 Portfolio in Review
As of Q4 2022, Adage Capital Partners held 1,140 positions worth $41.8B, up 3.7% from $40.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Adage Capital Partners withdrew a net $1.36B in Q4 2022, closing 166 positions and reducing 373 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $349M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in argenx worth $109M.
- Adage Capital Partners's largest Q4 2022 buy was argenx: 287,396 shares worth $109M.
- Adage Capital Partners added most to Chipotle Mexican Grill in Q4 2022, an estimated $197M increase.
- Adage Capital Partners's biggest Q4 2022 reduction was Burlington, cutting an estimated $186M.
- Adage Capital Partners fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $349M.
- Adage Capital Partners's ten largest holdings make up 19% of its $41.8B portfolio in Q4 2022.
- Adage Capital Partners opened 93 new positions and closed 166 in Q4 2022.
- Adage Capital Partners's portfolio value rose 3.7% quarter-over-quarter to $41.8B.
Based on Adage Capital Partners's 13F filing for Q4 2022, filed 14 Feb 2023.